REGENERON PHARMACEUTICALS shareholders Q1 2022

REGENERON PHARMACEUTICALS's ticker is REGN and the CUSIP is 75886F107. A total of 741 filers reported holding REGENERON PHARMACEUTICALS in Q1 2022. The put-call ratio across all filers is 1.80 and the average weighting 0.3%.

REGENERON PHARMACEUTICALS shareholders Q1 2022
NameSharesValueWeighting ↓
Bronte Capital Management Pty Ltd. 139,017$97,0928.16%
Tri Locum Partners LP 21,477$15,0005.86%
Karani Asset Management LLC 15,375$10,7385.81%
DCF Advisers, LLC 14,700$10,2674.50%
R.P. Boggs & Co. 8,963$6,2604.14%
HARVEY CAPITAL MANAGEMENT INC 16,893$11,7983.64%
Tekla Capital Management LLC 146,200$102,1093.59%
FOREFRONT WEALTH MANAGEMENT INC. 5,057$3,5323.49%
DE BURLO GROUP INC 26,190$18,291,6203.41%
Apriem Advisors 32,138$22,4463.29%
TAURUS ASSET MANAGEMENT, LLC 46,332$32,3593.26%
SEIZERT CAPITAL PARTNERS, LLC 81,605$56,9952.62%
PRENTISS SMITH & CO INC 6,176$4,3132.59%
ATWOOD & PALMER INC 41,051$28,6712.48%
NORTH POINT PORTFOLIO MANAGERS CORP/OH 23,666$16,5292.43%
LOOMIS SAYLES & CO L P 2,548,047$1,779,6072.38%
PREMIER ASSET MANAGEMENT LLC 10,176$7,1072.21%
Veracity Capital LLC 7,047$4,9222.04%
GRAHAM CAPITAL WEALTH MANAGEMENT, LLC 3,216$2,2462.00%
Bedell Frazier Investment Counseling, LLC 11,209$7,8291.98%

External links

This page lists REGENERON PHARMACEUTICALS's shareholders in Q1 2022. To view REGENERON PHARMACEUTICALS's shareholder history, click here.